ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,127.79
      1.26%
      US Tech 100
      17,446.00
      2.17%
      Dow Jones
      38,675.68
      1.18%
      Brent Oil
      82.765
      0.00%
      Bitcoin
      63,998.99
      0.17%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Immuron Ltd (IMRN)

      7. Immuron Ltd (IMRN) News

      IMRN Immuron Ltd

      2.52
      -0.02 (-0.79%)
      May 04 2024 - Closed
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Immuron Ltd IMRN NASDAQ Depository Receipt
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      -0.02 -0.79% 2.52 00:00:11
      Open Price Low Price High Price Close Price Prev Close
      2.62 2.4815 2.62 2.52 2.54
      more quote information »

      Recent News

      Date Time Source Heading
      5/03/202406:00GLOBEImmuron Director Resignation
      4/15/202406:00GLOBEImmuron to host Live Virtual Event
      4/10/202406:00GLOBEImmuron Travelan® sales continued strong growth
      3/07/202408:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      3/07/202406:00GLOBEImmuron Announces Positive Results Support Travelan®..
      2/28/202408:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      2/21/202408:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      2/21/202406:00GLOBEImmuron Presentation Australian Biologics Festival 2024
      2/13/202408:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      2/13/202406:00GLOBEImmuron achieves record Travelan® sales
      2/08/202406:00GLOBEImmuron CEO, Steven Lydeamore Investor Webinar Presentation
      1/16/202408:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      1/16/202406:00GLOBEImmuron achieves record half yearly Travelan® sales
      12/22/202307:21EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      12/22/202306:00GLOBEImmuron Clinical Trials Update
      12/04/202306:32EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      12/04/202306:00GLOBEImmuron Announces First Patients Enrolled in Campylobacter..
      11/28/202306:33GLOBEImmuron CEO, Steven Lydeamore Investor Webinar Presentation
      11/28/202306:17EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      11/22/202307:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      11/21/202306:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      11/13/202318:00GLOBEImmuron CEO Steven Lydeamore Investor Webinar Presentation
      11/13/202308:28EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      10/30/202308:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      10/30/202307:21GLOBEImmuron CEO Steven Lydeamore presented at AusBioInvest
      10/23/202308:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      10/18/202306:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      10/18/202306:00GLOBEImmuron Announces Travelan® Clinical Study Cohort 2..
      10/11/202306:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      10/11/202306:00GLOBEImmuron achieves record quarterly Travelan® sales
      9/28/202308:43EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      9/28/202306:18EDGAR2Form 20-F - Annual and transition report of foreign private..
      9/13/202306:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      9/13/202306:00GLOBEImmuron achieves record monthly Travelan® sales
      9/11/202306:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      9/11/202306:00GLOBEImmuron CEO, Steven Lydeamore to present at H.C. Wainwright
      8/30/202306:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      8/14/202306:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      8/14/202306:00GLOBEImmuron to present at the Military Health System Research..
      8/09/202306:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      7/25/202306:00GLOBEImmuron Announces First Patients Enrolled in Travelan®..
      7/24/202321:48EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      7/24/202306:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      7/24/202306:00GLOBEImmuron CEO, Steven Lydeamore to present at Bioshares
      7/11/202306:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      7/11/202306:00GLOBEImmuron Business Update - Ateria Health launches Juvia™ in..
      7/05/202306:00GLOBEImmuron FY23 Sales increase 136% on FY22 Sales
      6/30/202306:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
      6/30/202306:00GLOBEImmuron Chairman Transition
      6/22/202306:00GLOBEImmuron Business Update: Letter to Shareholders

      Your Recent History

      NASDAQ
      IMRN
      Immuron
      Delayed Upgrade Clock